Shilian Chen

677 total citations
18 papers, 433 citations indexed

About

Shilian Chen is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Shilian Chen has authored 18 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Cancer Research. Recurrent topics in Shilian Chen's work include Autophagy in Disease and Therapy (4 papers), RNA modifications and cancer (3 papers) and Ubiquitin and proteasome pathways (3 papers). Shilian Chen is often cited by papers focused on Autophagy in Disease and Therapy (4 papers), RNA modifications and cancer (3 papers) and Ubiquitin and proteasome pathways (3 papers). Shilian Chen collaborates with scholars based in China, United States and Saudi Arabia. Shilian Chen's co-authors include Guan‐Cheng Li, Chaoyang Zhang, Li Peng, Zhaoyang Liu, Wenling Li, Yaqin Zhang, Xuan Wu, Qian Lei, Yinghong Zhu and Jiaojiao Guo and has published in prestigious journals such as British Journal of Haematology, American Journal of Transplantation and BMC Genomics.

In The Last Decade

Shilian Chen

15 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shilian Chen China 10 296 150 103 101 60 18 433
Asmitananda Thakur China 15 356 1.2× 198 1.3× 91 0.9× 73 0.7× 34 0.6× 25 507
Liz J. Hernández Borrero United States 2 260 0.9× 120 0.8× 136 1.3× 68 0.7× 35 0.6× 2 441
Jianjiang Fu China 5 380 1.3× 146 1.0× 166 1.6× 75 0.7× 39 0.7× 5 591
Lokman Varışlı Türkiye 11 261 0.9× 100 0.7× 94 0.9× 88 0.9× 25 0.4× 28 410
Ranadip Mandal Germany 9 342 1.2× 83 0.6× 120 1.2× 91 0.9× 73 1.2× 11 516
Zhimin Fan China 15 319 1.1× 181 1.2× 140 1.4× 106 1.0× 19 0.3× 32 566
Maoxiao Feng China 14 509 1.7× 294 2.0× 131 1.3× 59 0.6× 72 1.2× 24 720
Xiaolong Ma China 17 388 1.3× 136 0.9× 99 1.0× 105 1.0× 46 0.8× 28 621
Xiaodong Pan China 9 278 0.9× 132 0.9× 38 0.4× 81 0.8× 87 1.4× 13 395

Countries citing papers authored by Shilian Chen

Since Specialization
Citations

This map shows the geographic impact of Shilian Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilian Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilian Chen more than expected).

Fields of papers citing papers by Shilian Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shilian Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilian Chen. The network helps show where Shilian Chen may publish in the future.

Co-authorship network of co-authors of Shilian Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Shilian Chen. A scholar is included among the top collaborators of Shilian Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilian Chen. Shilian Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Wei, Jie, et al.. (2025). Anthocyanins Delay D‐Galactose–Induced Mouse Liver Aging by Regulating the NFκB / IKK Signaling Pathway. Food Science & Nutrition. 13(4). e70161–e70161.
3.
Lin, Chengjie, Biao Lei, Shilian Chen, et al.. (2023). Complement inhibition alleviates donor brain death-induced liver injury and posttransplant cascade injury by regulating phosphoinositide 3-kinase signaling. American Journal of Transplantation. 23(4). 484–497. 5 indexed citations
4.
Peng, Bo, Shilian Chen, Kai Hu, et al.. (2023). Transcriptome sequencing and metabolome analysis reveal the metabolic reprogramming of partial hepatectomy and extended hepatectomy. BMC Genomics. 24(1). 532–532. 4 indexed citations
5.
Wang, Jiming, Yonglian Zeng, Huizhao Su, et al.. (2023). FBXL19 promotes malignant behaviours by activating MAPK signalling and negatively correlates with prognosis in hepatocellular carcinoma. Heliyon. 9(11). e21771–e21771. 2 indexed citations
6.
Zhou, Yi, Hao Huang, Yonglian Zeng, et al.. (2021). Baicalein pre‑treatment alleviates hepatic ischemia/reperfusion injury in mice by regulating the Nrf2/ARE pathway. Experimental and Therapeutic Medicine. 22(6). 1380–1380. 16 indexed citations
7.
Zeng, Yonglian, Zhenya Guo, Zhigao Hu, et al.. (2020). FGD1 exhibits oncogenic properties in hepatocellular carcinoma through regulating cell morphology, autophagy and mitochondrial function. Biomedicine & Pharmacotherapy. 125. 110029–110029. 13 indexed citations
8.
Guo, Zhenya, Yonglian Zeng, Shilian Chen, et al.. (2020). TRAIP promotes malignant behaviors and correlates with poor prognosis in liver cancer. Biomedicine & Pharmacotherapy. 124. 109857–109857. 15 indexed citations
9.
Wu, Xuan, Jiliang Xia, Jingyu Zhang, et al.. (2020). Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myeloma. British Journal of Haematology. 190(1). 52–66. 45 indexed citations
10.
Xia, Jiliang, Yanjuan He, Bin Meng, et al.. (2020). NEK2 induces autophagy‐mediated bortezomib resistance by stabilizing Beclin‐1 in multiple myeloma. Molecular Oncology. 14(4). 763–778. 71 indexed citations
11.
Wu, Xuan, Li Peng, Yaqin Zhang, et al.. (2019). Identification of Key Genes and Pathways in Cervical Cancer by Bioinformatics Analysis. International Journal of Medical Sciences. 16(6). 800–812. 41 indexed citations
12.
Zhu, Yinghong, Shi Chen, Liang Zeng, et al.. (2019). High COX‐2 expression in cancer‐associated fibiroblasts contributes to poor survival and promotes migration and invasiveness in nasopharyngeal carcinoma. Molecular Carcinogenesis. 59(3). 265–280. 50 indexed citations
13.
Chen, Shilian, Yaqin Zhang, Xuan Wu, Chaoyang Zhang, & Guan‐Cheng Li. (2018). Diagnostic Value of lncRNAs as Biomarker in Hepatocellular Carcinoma: An Updated Meta-Analysis. Canadian Journal of Gastroenterology and Hepatology. 2018. 1–12. 28 indexed citations
14.
He, Xu, Liang Zeng, Yongjun Guan, et al.. (2018). High NEK2 confers to poor prognosis and contributes to cisplatin‐based chemotherapy resistance in nasopharyngeal carcinoma. Journal of Cellular Biochemistry. 120(3). 3547–3558. 27 indexed citations
15.
Zhang, Chaoyang, Li Peng, Yaqin Zhang, et al.. (2017). The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data. Medical Oncology. 34(6). 101–101. 113 indexed citations
16.
Chen, Shilian. (2006). Knowledge Reduction Based on Graded Rough Set. Journal of Kunming University of Science and Technology.
17.
Chen, Shilian. (2005). Algorithm based on value reduction and decision tree to generate minimal rules. Jisuanji gongcheng. 2 indexed citations
18.
Chen, Shilian. (2001). The Grey Element and Grey Element Space in Grey Systems. Journal of Kunming University of Science and Technology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026